Biogen Inc (NASDAQ:BIIB)
| 239.34 Delayed Data As of Dec 08 |  +0.22 / +0.09%Today’s Change | 220.86 Today|||52-Week Range 319.76 | -13.57% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 9.3B | 10.2B | 11.0B | 12.1B | |
| Cost of Goods Sold | 1.0B | 1.1B | 1.4B | 1.5B | ||
| Depreciation And Amortization | 600.4M | 682.7M | 1.0B | 650.6M | ||
| Operating Expenses | Gross Income | 7.7B | 8.4B | 8.6B | 9.9B | |
| General Expenses | 4.1B | 3.9B | 4.2B | 4.7B | ||
| Research And Development | 2.0B | 2.0B | 2.3B | 2.6B | ||
| Total Operating Expenses | 5.7B | 5.7B | 6.6B | 6.9B | ||
| Non-Operating Expenses | Operating Income | 3.6B | 4.5B | 4.4B | 5.2B | |
| Extraordinary Credit | 0.00 | -- | 13.2M | 25.1M | ||
| Extraordinary Charge | -142.8M | -586.6M | -238.5M | -501.5M | ||
| Pre-Tax Equity Earnings | 1.3B | 1.2B | 1.2B | 1.2B | ||
| Interest Expense On Debt | 105.9M | 260.0M | 245.6M | 254.6M | ||
| Equity In Earnings | -12.5M | 0.00 | 0.00 | -- | ||
| Other Expenses | 141.8M | 10.7M | -88.8M | 54.6M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 4.8B | 4.9B | 5.1B | 5.9B | |
| Income Taxes | -1.2B | -1.2B | -2.5B | -1.4B | ||
| Minority Interest | -46.2M | -7.1M | -131.0M | -43.3M | ||
| Net Income | 3.5B | 3.7B | 2.5B | 4.4B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 230.7M | 218.4M | 212.6M | 204.9M | |
| Shares To Calculate EPS Diluted | 231.2M | 218.8M | 213.0M | 205.3M | ||
| Earnings Per Share | EPS | $15.34 | $16.93 | $11.92 | $21.58 | |
| EPS Diluted | $15.34 | $16.92 | $11.92 | $21.58 | ||
